NewAmsterdam Pharma Co N.V (NAMS) Treasury Shares: 2022-2025
Historic Treasury Shares for NewAmsterdam Pharma Co N.V (NAMS) over the last 2 years, with Sep 2025 value amounting to $724,908.
- NewAmsterdam Pharma Co N.V's Treasury Shares rose 19.08% to $724,908 in Q3 2025 from the same period last year, while for Sep 2025 it was $724,908, marking a year-over-year increase of 19.08%. This contributed to the annual value of $143,002 for FY2024, which is 76.51% down from last year.
- According to the latest figures from Q3 2025, NewAmsterdam Pharma Co N.V's Treasury Shares is $724,908, which was up 0.88% from $718,584 recorded in Q2 2025.
- Over the past 5 years, NewAmsterdam Pharma Co N.V's Treasury Shares peaked at $724,908 during Q3 2025, and registered a low of $143,002 during Q4 2024.
- Its 3-year average for Treasury Shares is $585,675, with a median of $608,779 in 2024.
- As far as peak fluctuations go, NewAmsterdam Pharma Co N.V's Treasury Shares crashed by 76.51% in 2024, and later increased by 19.08% in 2025.
- Quarterly analysis of 4 years shows NewAmsterdam Pharma Co N.V's Treasury Shares stood at $608,779 in 2022, then remained steady at $608,779 in 2023, then slumped by 76.51% to $143,002 in 2024, then increased by 19.08% to $724,908 in 2025.
- Its Treasury Shares stands at $724,908 for Q3 2025, versus $718,584 for Q2 2025 and $663,790 for Q1 2025.